DASATINIB and ADVERSE EVENT

Overview

ADVERSE EVENT is the #10 most commonly reported adverse reaction for DASATINIB, manufactured by E.R. Squibb & Sons, L.L.C.. There are 1,462 FDA adverse event reports linking DASATINIB to ADVERSE EVENT. This represents approximately 2.6% of all 55,495 adverse event reports for this drug.

Patients taking DASATINIB who experience adverse event should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ADVERSE EVENT is a less commonly reported adverse event for DASATINIB, but still significant enough to appear in the safety profile.

Other Side Effects of DASATINIB

In addition to adverse event, the following adverse reactions have been reported for DASATINIB:

• PLEURAL EFFUSION — 3,168 reports
• FATIGUE — 2,515 reports
• DIARRHOEA — 2,155 reports
• NAUSEA — 2,115 reports
• DEATH — 2,068 reports
• HEADACHE — 1,984 reports
• RASH — 1,586 reports
• DRUG INEFFECTIVE — 1,485 reports
• DYSPNOEA — 1,479 reports
• OFF LABEL USE — 1,218 reports

Other Drugs Associated with ADVERSE EVENT

The following drugs have also been linked to adverse event in FDA adverse event reports:

Does DASATINIB cause ADVERSE EVENT?

ADVERSE EVENT has been reported as an adverse event in 1,462 FDA reports for DASATINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ADVERSE EVENT with DASATINIB?

ADVERSE EVENT accounts for approximately 2.6% of all adverse event reports for DASATINIB, making it a notable side effect.

What should I do if I experience ADVERSE EVENT while taking DASATINIB?

If you experience adverse event while taking DASATINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages